Cargando…
Urinary 11‐dehydrothromboxane B(2) concentrations in 20 dogs with primary immune‐mediated hemolytic anemia
BACKGROUND: Thromboembolic disease is a major cause of mortality in dogs with immune‐mediated hemolytic anemia (IMHA). At present, no reliable biomarkers of individual patient thrombotic risk are available. In human medicine, increased urinary thromboxane concentrations have utility as markers of pr...
Autores principales: | Conway, Elizabeth A., Evans, Neil P., Ridyard, Alison E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783321/ https://www.ncbi.nlm.nih.gov/pubmed/34859495 http://dx.doi.org/10.1111/jvim.16322 |
Ejemplares similares
-
Predicting Outcome in dogs with Primary Immune‐Mediated Hemolytic Anemia: Results of a Multicenter Case Registry
por: Goggs, R., et al.
Publicado: (2015) -
Serum interleukin 17 concentrations in dogs with immune‐mediated hemolytic anemia
por: Cuq, Benoît, et al.
Publicado: (2020) -
Reactive oxygen species, glutathione, and vitamin E concentrations in dogs with hemolytic or nonhemolytic anemia
por: Woolcock, Andrew D., et al.
Publicado: (2020) -
Carboxyhemoglobin as a diagnostic and prognostic biomarker of hemolytic anemias in dogs
por: Nivy, Ran, et al.
Publicado: (2022) -
Splenectomy in the management of primary immune‐mediated hemolytic anemia and primary immune‐mediated thrombocytopenia in dogs
por: Bestwick, Jason P., et al.
Publicado: (2022)